Breaking News
February 17, 2019 - New method analyzes how single biological cells react to stressful situations
February 17, 2019 - WVU gynecologic oncologist investigates novel treatment for cervical and vaginal cancers
February 17, 2019 - ADHD diagnoses poorly documented
February 17, 2019 - Majority of gender minority youth do not identify with traditional sexual identity labels
February 17, 2019 - AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma
February 17, 2019 - Lower Birth Weight May Up Risk for Psychiatric Disorders
February 17, 2019 - Scientists identify reversible molecular defect underlying rheumatoid arthritis
February 17, 2019 - Moffitt researchers shed light on how CAR T cells function mechanistically
February 16, 2019 - Female Anatomy May Play Big Role in Sperm’s Success
February 16, 2019 - BMI may mediate inverse link between fiber intake, knee OA
February 16, 2019 - Movement impairments in autism can be reversed through behavioral training
February 16, 2019 - Studies address racial disparities in postpartum period and cardiovascular health
February 16, 2019 - Scientists implicate hidden genes in the severity of autism symptoms
February 16, 2019 - Decreased deep sleep linked to early signs of Alzheimer’s disease
February 16, 2019 - Neuroscientists show how the brain responds to texture
February 16, 2019 - Gilead Announces Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)
February 16, 2019 - What Can I Do About Sweating? (for Teens)
February 16, 2019 - Companies navigate dementia conversations with older workers
February 16, 2019 - Newly developed stem cell technologies show promise for treating PD patients
February 16, 2019 - Collaborative material research could advance self-assembling nanomaterials
February 16, 2019 - Researchers take major step in creating technology that mimics the human brain
February 16, 2019 - Erasing memories associated with cocaine use reduces drug seeking behavior
February 16, 2019 - Artificial intelligence can accurately predict prognosis of ovarian cancer patients
February 16, 2019 - Racial disparities in cancer deaths on the decline for America
February 16, 2019 - FDA authorizes new interoperable insulin pump for children, adults with diabetes
February 16, 2019 - Coexisting Medical Conditions, Smoking Explain PTSD-CVD Link
February 16, 2019 - Skin Cancer Screening: MedlinePlus Lab Test Information
February 16, 2019 - ‘Happiness’ exercises can boost mood in those recovering from substance use disorder
February 16, 2019 - Cell manipulation could soon halt or reverse aging
February 16, 2019 - Pumped Breast Milk Falls Short of Breastfed Version
February 16, 2019 - Men’s porn habits could fuel partners’ eating disorders, study suggests
February 16, 2019 - Rapid progression of age-related diseases may result from formation of vicious cycles
February 16, 2019 - Immune checkpoint molecule protects against future development of cancer
February 16, 2019 - New method produces hydrogels that have properties similar to cells’ environment
February 16, 2019 - $4.1 million funding for heart research on Valentine’s Day
February 16, 2019 - General anesthesia in early infancy unlikely to have lasting effects on developing brains
February 16, 2019 - New breakthroughs for muscular dystrophy research
February 16, 2019 - First Opinion: Embryo editing for higher IQ is a fantasy. Embryo profiling for it is almost here
February 16, 2019 - Vapers develop cancer-related gene deregulation as cigarette smokers
February 16, 2019 - Bringing Antimicrobial Susceptibility Testing (AST) to the Community
February 16, 2019 - Decolonization protocol after hospital discharge can prevent dangerous infections
February 16, 2019 - Children with ASD more likely to face maltreatment, study finds
February 16, 2019 - Study finds genetic vulnerability to use of menthol cigarettes
February 16, 2019 - H-RT should be the standard of care for men with low risk prostate cancer, study shows
February 16, 2019 - New technique using patients’ own modified cells could help treat Crohn’s disease
February 16, 2019 - Therapeutic endoscopy has an expanding role in the treatment of IBD
February 16, 2019 - Blood clot discovery could lead to development of better treatments for blood diseases
February 16, 2019 - Intervention can increase exclusive breastfeeding rates
February 16, 2019 - New project explores how gaming technologies can help cancer patients communicate better
February 16, 2019 - Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress
February 16, 2019 - Rerouting nerves during amputation reduces phantom limb pain before it starts
February 16, 2019 - A Hormone Produced When We Exercise Might Help Fight Alzheimer’s
February 16, 2019 - Millions of British people breathe toxic air travelling to GPs
February 16, 2019 - Conformance of genetic characteristics found to be crucial for longer preservation of kidney graft
February 16, 2019 - Researchers use optogenetic tool to control, visualize receptor signals in neural cells
February 16, 2019 - New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
February 16, 2019 - Testosterone is not the only hormone needed for penis development
February 16, 2019 - FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression
February 15, 2019 - Heart surgery technology developed at Baptist Health debuts after years of secrecy
February 15, 2019 - Prescription Opioids Double Risk of Triggering Fatal Car Crash
February 15, 2019 - New study helps doctors better understand high blood pressure in pregnant women
February 15, 2019 - Beta wave control in Parkinson’s diseased brain could be a potential therapy
February 15, 2019 - Media representations of love may justify gender-based violence in young people
February 15, 2019 - Yoga May Help With Rheumatoid Arthritis Symptoms, Severity
February 15, 2019 - Obstructive sleep apnea linked to inflammation, organ dysfunction
February 15, 2019 - Master your mind: A challenge from WELL for Life
February 15, 2019 - Why Some Brain Tumors Respond to Immunotherapy
February 15, 2019 - Must-Reads Of The Week From Brianna Labuskes
February 15, 2019 - Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s
February 15, 2019 - Genetic variations in a fourth gene associated with higher ALL risk in Hispanic children
February 15, 2019 - Disruptive behavioral problems in kindergarten linked with lower employment earnings in adulthood
February 15, 2019 - New bioengineered device enhances the production of T-cells
February 15, 2019 - HDL proteome behaves like a tiny Velcro ball that is rolling on surfaces
February 15, 2019 - Puerto Rican children more likely to have poor or decreasing use of asthma inhalers
February 15, 2019 - Quality of patient care does not improve after physician-hospital integration
February 15, 2019 - Synopsys release new software for implant design and patient-specific planning
February 15, 2019 - 6 out of 10 hip replacements last 25 years or longer
February 15, 2019 - Health Tip: What You Should Know About Antibiotics
February 15, 2019 - New research challenges medical consensus that adenoids and tonsils significantly shrink during teenage years
February 15, 2019 - Discovery of weakness in a rare cancer could be exploited with drugs
Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear

Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear

image_pdfDownload PDFimage_print

About one decade after its first benefit assessment of negative pressure wound therapy (NPWT), the German Institute for Quality and Efficiency in Health Care (IQWiG) is reassessing this treatment method. However, then as now, its benefit and harm are unclear. Whereas only few studies with very limited informative value were available in 2006, over 100 clinical comparisons with several thousands of patients have been conducted since. But results have been published for only some of these studies, as not only the manufacturers of the medical devices used, but also researchers, are concealing data, thus violating ethical and scientific standards. Assessing the benefit and harm of the treatment solely on the basis of the published data could have entailed a seriously biased result. Hence, there is still no valid basis for the assessment of the benefit and harm of this treatment.

The current report deals with NPWT for wounds healing by secondary intention; wounds healing by primary intention are the subject of a second benefit assessment. In NPWT, negative pressure in the wound is used to promote wound healing, and to accelerate the healing of large wounds in particular.

Over 100 studies with several thousands of participants

The Institute has now found that a large number of further randomized controlled trials (RCTs) comparing NPWT with standard treatment have been completed since its last report. There are currently over 100 studies involving several thousands of patients, which is an unusually large number for a non-drug intervention. One would think that this would be a good starting point for a benefit assessment.

Publication bias: positive effect often overestimated

The inclusion of the results of all studies in the assessment is indispensable to be able to draw reliable conclusions. The use of only published data could lead to an overestimation of the positive effects of a medical intervention, because it is known from research that studies with “unfavorable” results are usually the ones that remain in the file drawer or are published only years later. This is referred to as “publication bias”.

For this reason, IQWiG not only conducts searches in databases or registries, but also sends requests to manufacturers and authors who have reported studies in journals, trial registries or presentations, for example. “Detective work” is sometimes required to identify studies.

Agreement with sponsors to facilitate cooperation

To be able to also use the results from studies sponsored by manufacturers as completely as possible and to facilitate cooperation, the Institutes regularly offers a contract to such sponsors, which has advantages for both sides: Confidential information such as confidential business and commercial information remains protected in any case. In return, the manufacturer agrees to submit the complete data on all published and unpublished studies. IQWiG may use and publish the results and the underlying methods.

The Institute has concluded such a contract with several manufacturers of NPWT systems. This is a comprehensive agreement, i.e. irrespective of a division of the commission by type of wound (primary, secondary).

Data missing for a large proportion of relevant studies

Many of the newly searched RCTs recorded and reported usable data on so-called patient-relevant outcomes such as mortality, wound closure, pain, complications (of treatment), length of hospital stay, or need of long-term care, and were therefore relevant for the assessment. However, there were also a large number of studies for which the results were not available, although the Institute had repeatedly requested information from the respective study investigators.

KCI does not comply with the contract

Despite several requests, the US-based manufacturer KCI Medical Devices (Acelity) provided neither a complete overview nor complete clinical study reports on all the studies for which the company is responsible. As a result, data were incomplete for half of all participants (842 of 1681). The IQWiG researchers therefore could not consider these studies for their benefit assessment of NPWT.

Standards violated also by researchers

However, there are also gaps in the remaining studies, most of them so-called investigator-initiated trials (IITs), which were, for example, initiated by university-based researchers: Regarding secondary wound healing, usable study results were missing for at least 1703 of 4251 participants in total, corresponding to 40%. Since this magnitude impedes a meaningful interpretation of the results, here too, the Institute dispensed with an assessment of benefit and harm.

Nothing is known about the researchers’ motives. Their own research interests or dependencies might play a role. It is obvious at least for some of the IITs that even though the manufacturers did not act as sponsors, they were involved indirectly, e.g. by granting scholarships or by supporting the analysis of the data and the production of manuscripts (medical writing).

Concealing data harms patients and physicians

Stefan Sauerland, Head of the Department of Non-Drug Interventions, notes with frustration: “The evidence base was meager when we conducted our first assessments. Now there are studies with several thousands of patients, but we still cannot say whether NPWT is better, equivalent, or possibly even worse than conventional wound treatment.”

The reason is that both companies and researchers are concealing data. “This violates ethical and scientific standards”, says Stefan Sauerland. “And they harm patients and physicians as well as the community of insured citizens, which to me, as a physician and researcher, is very disconcerting.”

Registration and publication of the results must be mandatory

NPWT is an example showing that further legal regulations are required, also for studies on non-drug interventions and medical devices. Unlike in other countries such as the United States, medical devices in Europe are not subject to a central approval process. A certification by “designated bodies”, which are private sector organizations, is sufficient to launch a medical device. In many cases, clinical studies have not been necessary for this, even though Europe’s Medical Device Directive is a considerable improvement for the requirements of a clinical assessment. In addition, in Germany, almost all new non-drug interventions can be used in hospitals and be reimbursed by statutory health insurance funds without prior assessment of their benefit or harm. A positive benefit assessment is only required for the outpatient sector.

New legislation would have to stipulate the registration of studies on non-drug interventions or medical devices before their start and the timely publication of their results. “More progress has been made in drug studies”, says Stefan Sauerland. An EU directive and the German Act on the Reform of the Market for Medicinal Products (AMNOG) have notably increased transparency regarding drugs. Stefan Sauerland is convinced: “Without similar regulations, reliable data on interventions such as NPWT will still not be available in 10 years’ time.”

Source:

https://www.iqwig.de/en/press/press-releases/negative-pressure-wound-therapy-violation-of-ethical-and-scientific-standards.10021.html

Tagged with:

About author

Related Articles